The Global Internal Nasal Dilators Market is Anticipated to Witness High Growth Owing to Rising Demand for Improving Breathing
The internal nasal dilators market involves nasal dilators
that are inserted inside the nostrils to enable easier breathing. Nasal
dilators offer relief from nasal congestion by improving airflow inside the
nasal cavity. They work by gently pulling back the sides of the nose to widen
the nasal passages. There has been a rising prevalence of nasal disorders such
as nasal congestion, chronic sinusitis, and allergic rhinitis. This has led to
high demand for nasal dilators to improve breathing. Nasal congestion is
commonly experienced by individuals during pregnancy, seasonal allergies, and
as a side-effect of common cold, flu, or chronic respiratory conditions.
Key manufacturers offer a variety of FDA-approved medical-grade internal nasal
dilators made with hypoallergenic materials. They are affordable, reusable, and
provide a non-invasive solution to nasal congestion. Their small, low-profile
design allows for discreet use during daytime activities, exercise, or sleep.
The Global Internal
Nasal Dilators Market is estimated to be valued at US$ 10.11 Bn in 2024 and
is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the Internal Nasal Dilators market are Becton,
Dickinson and Company, Gerresheimer AG, Sharps Technology, Inc., Cardinal
Health, lomMedical, MHC Medical Products, LLC, Sol-Millennium, UltiMed Inc.,
VOGT MEDICAL, Retractable Technologies, Inc., Dmcmedical, BIOCORP, Hindustan
Syringes & Medical Devices Ltd, Owen Mumford Ltd., B. Braun SE, Terumo
Europe NV, Smiths Group plc, Merit Medical Systems, Nipro Corporation, GPC
Medical Ltd., AdvaCare Pharma.
The rising awareness about nasal congestion relief products and availability of
innovative dilator designs present lucrative opportunities in the market. There
is an increasing demand for nasal dilators catering to different age groups and
activity levels. Manufacturers are launching small, discreet, and comfortable
dilators suitable for varied consumer needs.
Key players have been expanding their geographical presence through partnership
with regional distributors. The internal nasal dilators market exhibits high
growth potential in developing regions of Asia Pacific and Latin America.
Rising healthcare expenditure and growing middle-class population are
encouraging multinational companies to invest in these emerging economies.
Market Drivers and Restraint
Growing sedentary lifestyle among urban populations with surge in respiratory
issues such as nasal congestion and allergies is a major market driver. Changes
in dietary habits and high pollution levels have led to the rise of respiratory
disorders, bolstering the demand for dilators. Technological advances in
materials and dilator design have made products more effective and comfortable
to use. This is encouraging higher product adoption.
Availability of alternative drug therapies and surge in generic drug prices
pose a challenge to market growth. Strict regulatory approvals for new dilator
devices also hamper speedy product launches. Presence of local manufacturers
providing low-cost alternatives has increased price competition in the market.
Segment Analysis
The internal nasal dilators market is dominated by the internal springs/braces
sub-segment which holds around 60% market share. Internal springs/braces
provide a continuous gentle stretch force to open the nasal passages. They are
reusable, effective, and provide long lasting relief of up to 12 hours from
nasal congestion. Other prominent sub-segments include adhesive nasal dilators
and nasal cones. However, internal springs/braces are more preferred due to
their longer duration of effect.
Global Analysis
North America dominates the internal nasal dilators market with the largest
market share of over 35% globally. Higher awareness regarding nasal congestion
relief products and growing adoption of seasonal allergies management products
drive the market in the region. Asia Pacific is expected to witness the highest
growth during the forecast period due to rising healthcare expenditure, large
patient population for allergic rhinitis, and growing awareness regarding nasal
problems. However, high treatment costs for branded nasal dilators remain a key
restraint in developing markets.
Comments
Post a Comment